Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies

Effectiveness of levetiracetam (LEV) in treatment of typical benign rolandic epilepsy and variants of benign idiopathic focal epilepsies was studied in 32 children (mean age 10.6 years, range 4-14) by researchers at Epilepsy Centre for Children and Young People, Vogtareuth, Germany.

Bibliographic Details

Published in:	Pediatric Neurology Briefs
Main Author:	J Gordon Millichap
Format:	Article
Language:	English
Published:	Pediatric Neurology Briefs Publishers 2010-03-01
Subjects:	levetiracetam benign idiopathic focal epileptiform discharges epileptiform discharges
Online Access:	https://www.pediatricneurologybriefs.com/articles/806